FIELD: medicine. SUBSTANCE: method involves analyzing endogenous substances like metalloproteinase or its precursor in body fluids like blood and urine to detect significant increase in endogenous substances concentration after chronic rejection process begins after kidney transplantation has taken place. EFFECT: enhanced effectiveness of method. 10 cl, 2 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| APPLYING 15-DEOXYSPERGUALINE FOR TREATMENT OF HYPER-REACTIVE INFLAMMATORY AND AUTOIMMUNE DISEASES | 2000 |
|
RU2255732C2 |
| DIAGNOSTIC METHOD FOR RENAL ALLOGRAFT REJECTION | 2007 |
|
RU2348932C1 |
| METHOD FOR PRODUCING REGULATORY DENDRITIC CELLS | 2011 |
|
RU2597976C2 |
| PHARMACEUTICAL COMPOSITION FOR PROPHYLAXIS OR TREATMENT OF DISEASES CAUSED BY IL-6 FORMATION | 1995 |
|
RU2147442C1 |
| METHOD OF PREPARING OPTICALLY ACTIVE ESTERS OF ERYTHRO-3-AMINO-2- HYDROXYBUTYRIC ACIDS AND CORRESPONDING ACIDS | 1997 |
|
RU2169138C2 |
| PHARMACEUTICAL COMPOSITION | 1992 |
|
RU2095061C1 |
| [1,2,4]TRIAZOLO[1,5-a]PYRIMIDINE-2-YLUREA DERIVATIVE AND ITS APPLICATION | 2004 |
|
RU2348636C2 |
| CHRONIC REJECTION INHIBITOR | 2008 |
|
RU2450829C2 |
| DERIVATIVES OF PHENANTHRIDINIUM SHOWING ANTITUMOR ACTIVITY, METHOD OF INHIBITION OF CANCER CELLS GROWTH | 1997 |
|
RU2183626C2 |
| NOVEL DERIVATIVES OF ACETAMIDE, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION AND PROTEASE INHIBITORS BASED ON THEREOF | 1997 |
|
RU2181360C2 |
